Categories
News

Gene Therapy Market gaining traction due to new market developments, says Polaris Analysts

Polaris Market Research recently updated its existing market research study on the Gene Therapy Market and estimates that the market would reach USD 4,300 million by 2021. The report provides historical data along with forecast till 2026. The report covers market trends, drivers and opportunity analysis and provides competitor benchmarking information. The report covers an exhaustive list of market tables and figures, thus providing in-depth analytical data for segments across different regions.

The updated report on the Gene Therapy Market is segmented by Therapeutics and by Regions. Major companies covered in the report include:

  • Novartis Pharmaceuticals Corporation
  • Kite Pharma, Incorporated
  • Spark Therapeutics, Inc
  • GlaxoSmithKline
  • Adaptimmune
  • Bluebird bio
  • Celgene
  • Shanghai Sunway Biotech
  • Shenzhen SiBiono GeneTech
  • SynerGene Therapeutics

 

For more information, request a sample of the study on https://www.polarismarketresearch.com/industry-analysis/gene-therapy-market/request-for-sample

The study evaluates the overall Gene Therapy Market by the following segments:

  • Historical Marketed Gene Therapies [2003-2012]
    • Rexin-G (Epeius Biotechnologies Corporation)
    • Gendicine (SiBiono GeneTech Co., Ltd)
    • Neovasculgen [Human Stem Cells Institute (HSCI))
    • Glybera (UniQure Biopharma B.V.)
  • First Countries to get an access to Gene Therapies
    • Philippines for Rexin-G [2003]
    • China for Gendicine [2003]
    • Russia for Neovasculgen [2011]
    • Selected European Countries for Glybera

 

The report attributes are as follows:

  • Historical Data (Actuals): 2015, 2016, 2017
  • Base Year: 2016
  • Estimates & Forecast: 2019 to 2021

The report can be customized on the basis of regional analysis, segment analysis, industry outlook and competitive analysis. Some of the major focus points which are covered in the report include:

  • Industry Trends, opportunity and challenges in the market
  • Role of key players across the value chain
  • End-User analysis to define the market strategy
  • Competitive mapping
  • Regional and country level breakdown

These insights are included in the report which would help you to have a realistic overview of the overall market including the competition, investment opportunities, restraints and challenges, regulatory factors which might affect the market growth. Moreover, the report would help to identify the regional market growth opportunities for different segments covered in the report.

Speak to Analyst to know more @ https://www.polarismarketresearch.com/industry-analysis/gene-therapy-market/speak-to-analyst

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world

Contact Us

Polaris Market Research

Phone: +44-203-287-6050

Email: [email protected]

Web: www.polarismarketresearch.com

Categories
News

Gene Therapy Market gaining traction due to new market developments, says Polaris Analysts

Polaris Market Research recently updated its existing market research study on the Gene Therapy Market and estimates that the market would reach USD 4,300 million by 2021. The report provides historical data along with forecast till 2026. The report covers market trends, drivers and opportunity analysis and provides competitor benchmarking information. The report covers an exhaustive list of market tables and figures, thus providing in-depth analytical data for segments across different regions.

The updated report on the Gene Therapy Market is segmented by Therapeutics and by Regions. Major companies covered in the report include:

  • Novartis Pharmaceuticals Corporation
  • Kite Pharma, Incorporated
  • Spark Therapeutics, Inc
  • GlaxoSmithKline
  • Adaptimmune
  • Bluebird bio
  • Celgene
  • Shanghai Sunway Biotech
  • Shenzhen SiBiono GeneTech
  • SynerGene Therapeutics

 

For more information, request a sample of the study on https://www.polarismarketresearch.com/industry-analysis/gene-therapy-market/request-for-sample

The study evaluates the overall Gene Therapy Market by the following segments:

  • Historical Marketed Gene Therapies [2003-2012]
    • Rexin-G (Epeius Biotechnologies Corporation)
    • Gendicine (SiBiono GeneTech Co., Ltd)
    • Neovasculgen [Human Stem Cells Institute (HSCI))
    • Glybera (UniQure Biopharma B.V.)
  • First Countries to get an access to Gene Therapies
    • Philippines for Rexin-G [2003]
    • China for Gendicine [2003]
    • Russia for Neovasculgen [2011]
    • Selected European Countries for Glybera

 

The report attributes are as follows:

  • Historical Data (Actuals): 2015, 2016, 2017
  • Base Year: 2016
  • Estimates & Forecast: 2019 to 2021

The report can be customized on the basis of regional analysis, segment analysis, industry outlook and competitive analysis. Some of the major focus points which are covered in the report include:

  • Industry Trends, opportunity and challenges in the market
  • Role of key players across the value chain
  • End-User analysis to define the market strategy
  • Competitive mapping
  • Regional and country level breakdown

These insights are included in the report which would help you to have a realistic overview of the overall market including the competition, investment opportunities, restraints and challenges, regulatory factors which might affect the market growth. Moreover, the report would help to identify the regional market growth opportunities for different segments covered in the report.

Speak to Analyst to know more @ https://www.polarismarketresearch.com/industry-analysis/gene-therapy-market/speak-to-analyst

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world

Contact Us

Polaris Market Research

Phone: +44-203-287-6050

Email: [email protected]

Web: www.polarismarketresearch.com

Categories
Analysis Forecast Market Price Analysis Market Reports Market Size

Gene Therapy Market Analytical Overview, Growth Factors, Demand and Trends Forecast to 2026

Polaris Market Research recently updated its existing market research study on the Gene Therapy Market and estimates that the market would reach USD 4,300 million by 2021. The report provides historical data along with forecast till 2026. The report covers market trends, drivers and opportunity analysis and provides competitor benchmarking information. The report covers an exhaustive list of market tables and figures, thus providing in-depth analytical data for segments across different regions.

The updated report on the Gene Therapy Market is segmented by Therapeutics and by Regions. Major companies covered in the report include:

  • Novartis Pharmaceuticals Corporation
  • Kite Pharma, Incorporated
  • Spark Therapeutics, Inc
  • GlaxoSmithKline
  • Adaptimmune
  • Bluebird bio
  • Celgene
  • Shanghai Sunway Biotech
  • Shenzhen SiBiono GeneTech
  • SynerGene Therapeutics

For more information, request a sample of the study on https://www.polarismarketresearch.com/industry-analysis/gene-therapy-market/request-for-sample

The study evaluates the overall Gene Therapy Market by the following segments:

  • Historical Marketed Gene Therapies [2003-2012]
    • Rexin-G (Epeius Biotechnologies Corporation)
    • Gendicine (SiBiono GeneTech Co., Ltd)
    • Neovasculgen [Human Stem Cells Institute (HSCI))
    • Glybera (UniQure Biopharma B.V.)
  • First Countries to get an access to Gene Therapies
    • Philippines for Rexin-G [2003]
    • China for Gendicine [2003]
    • Russia for Neovasculgen [2011]
    • Selected European Countries for Glybera

The report attributes are as follows:

  • Historical Data (Actuals): 2015, 2016, 2017
  • Base Year: 2016
  • Estimates & Forecast: 2019 to 2021

The report can be customized on the basis of regional analysis, segment analysis, industry outlook and competitive analysis. Some of the major focus points which are covered in the report include:

  • Industry Trends, opportunity and challenges in the market
  • Role of key players across the value chain
  • End-User analysis to define the market strategy
  • Competitive mapping
  • Regional and country level breakdown

These insights are included in the report which would help you to have a realistic overview of the overall market including the competition, investment opportunities, restraints and challenges, regulatory factors which might affect the market growth. Moreover, the report would help to identify the regional market growth opportunities for different segments covered in the report.

Speak to Analyst to know more @ https://www.polarismarketresearch.com/industry-analysis/gene-therapy-market/speak-to-analyst

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world

Contact Us

Polaris Market Research

Phone: +44-203-287-6050

Email: [email protected]

Web: www.polarismarketresearch.com

Categories
News

Gene Therapy Market is Projected to Expand at a CAGR of 40.0% from 2018 to 2026

Transparency Market Research (TMR) has published a new report titled, “Gene Therapy Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global gene therapy market was valued at US$ 17.0 Mn in 2017 and is projected to expand at a CAGR of 40.0% from 2018 to 2026. New product approvals, promising therapeutic outcomes of gene therapy, and high prevalence of non-Hodgkin Lymphoma are anticipated to drive the global market in the next few years. Europe is projected to dominate the global gene therapy market, followed by U.S., by the end of 2026. Potential unmet needs in the fields of oncology, rare genetic disorders in the U.S. and Europe, new product approvals and commercialization, and high clinical R&D budgets are likely to drive the gene therapy market in these regions during the forecast period. The gene therapy market in Rest of World is projected to expand at a significant CAGR during the forecast period. The high growth rate is attributed to the anticipated approval and commercialization of gene therapy products in developed countries such as Japan, Australia & New Zealand, GCC countries, and China, and high prevalence of non-Hodgkin Lymphoma and head and neck cancers.

Request a PDF Sample – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1838

New product approvals & commercialization drives market

2016, 2017, and 2018 were key milestones in the history of the gene therapy market in the U.S. and Europe, as around four gene therapy products have been approved and commercialized. These products are currently in the infancy stage of commercialization, and have exhibited highly positive therapeutic outcomes. For instance, in May 2016, GlaxoSmithKline (GSK) gene therapy product, Strimvelis, received marketing approval for the treatment of patients with a very rare disease called ADA-SCID (Severe Combined Immunodeficiency, due to Adenosine Deaminase deficiency). Strimvelis is the first ex-vivo stem cell gene therapy to be approved in Europe for the treatment of ADA-SCID. Furthermore, in August 2017, the USFDA approved Novartis AG’s flagship gene therapy product, Kymriah, for the treatment of children and adults up to the age of 25 years affected with B-cell precursor acute lymphoblastic leukemia (ALL). Thus, recent approvals of gene therapy products in the U.S. and Europe for the treatment of various life threatening disorders is projected to fuel the gene therapy market during the forecast period.

Yescarta to be highest revenue generating gene therapy product

The report offers a detailed segmentation of the global gene therapy market based on different gene therapy products approved and commercialized. Based on product, the global gene therapy market has been segmented into Yescarta, Kymriah, Luxturna, Strimvelis, and Gendicine. Yescarta (Axicabtagene Ciloleucel) is a genetically modified autologous Chimeric Antigen Receptor T (CAR T) cell immunotherapy developed by Gilead Sciences, Inc. for the treatment of adult patients with relapsed or refractory large B-cell lymphoma including diffuse large B-cell lymphoma (DLBCL) and primary mediastinal large B-cell lymphoma (PMBCL). It is the first CAR T therapy approved by the US FDA for the treatment of DLBCL. The Yescarta segment is projected to dominate the global gene therapy market by the end of 2026. Anticipated commercialization of Yescarta in Europe and other developed countries and increasing number of treatment centers are key factors that are likely to lead to the dominant share held by Yescarta by the end of 2026.

Request for Analysis of COVID19 Impact on Gene Therapy Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1838

Oncology segment to account for high market share

In terms of application, the global gene therapy market has been segmented into ophthalmology, oncology, and adenosine deaminase ?deficient severe combined immunodeficiency (ADA-SCID). The oncology segment is likely to account for a significant share of the market by the end of 2026. Oncology is a highly studied medical field in the clinical pipeline studies of gene therapy candidates. More than 60% of gene therapy clinical research studies are focused on oncology. The large share held by the oncology segment is attributed to the approval and commercialization of Yescarta and Kymriah, in the last one to two years, for the treatment of certain types of non-Hodgkin lymphoma in the U.S. and Europe. Furthermore, increase in demand for Gendicine in China for the treatment of head and neck cancers is projected to drive the segment during the forecast period.

Europe offers high incremental opportunity

The gene therapy market in Europe is projected to expand at a significant CAGR of 30.6% during the forecast period. Large number of patient population with refractory large B-cell lymphoma, including diffuse large B-cell lymphoma (DLBCL) and primary mediastinal large B-cell lymphoma (PMBCL), promising therapeutic outcomes, rising demand for gene therapy treatment, and increasing number of gene therapy treatment centers in Europe are key factors that are likely to fuel the gene therapy market in Europe. Moreover, different pricing models are being evaluated by payers and governments to enable access to high priced gene therapy products. This is likely to drive the demand for gene therapy products in Europe during the forecast period.

Purchase Gene Therapy Market Report – https://www.transparencymarketresearch.com/checkout.php?rep_id=1838&ltype=S

Large number of clinical pipeline studies and significant investments in gene therapy to gain the first mover advantage

The global gene therapy market is highly consolidated, with very few global players accounting for a major share. Currently, only five companies; Gilead life Sciences Inc. Spark Therapeutic Inc., Novartis AG, Sibiono GeneTech Co. Ltd, and Orchard Therapeutics Limited offer gene therapy products in the market. Most biopharmaceutical companies have invested significantly in clinical R&D for the development of gene therapy products for different chronic and genetic disorders. Large number of gene therapy products are under different stages of clinical pipeline studies, and the number of gene therapy candidates is projected to rise consistently during the forecast period. For instance, according to the Journal of Gene Medicine, there were around 2,597 gene therapy candidates under clinical trials, as of 2017. Of the total clinical studies, around 65% of studies were focused on oncology, 11% of studies were focused on monogenetic field, 7% on infectious diseases and cardiovascular disease, each.

More Trending Reports by Transparency Market Research –

Fetal Monitoring Systems Market: https://www.prnewswire.com/news-releases/innovation-in-wearable-devices-driving-fetal-monitoring-systems-market-to-upward-growth-trajectory-tmr-301015185.html

Read our Case study at https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,

90 Sate Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

Categories
Analysis Forecast Market Price Analysis Market Reports Market Size News

Gene Therapy Market Growth, SWOT Analysis by Top Vendors and Forecast Report to 2028

Quince Market Insights has recently released a market report which provides an in-depth understanding of various drivers and opportunities that are expected to shape the development of a market for Gene therapy . This report highlights further the structure of the Gene therapy market in several regions and analyzes the business environment in individual regions.

The research report for global Gene therapy market consists of the valuation for a period from 2020 to 2028. The global study on Gene therapy also provides qualitative industry perspectives such as engines, barriers, value chain, regulatory framework and trade statistics. The supply chain of main stages has been studied in depth.

For more information, download sample of the premium report https://www.quincemarketinsights.com/request-sample-60261?utm_source=campaign=Pooja/PF

Quince Market Insights | LinkedIn

The size of the global Gene therapy market is expected to reach USD xxx billion by 2028. During the forecast period, the global Gene therapy market is expected to expand at an x.x per cent CAGR.

In order to provide a deep understanding of different aspects of the Gene therapy market at the granular level, the Gene therapy market is split into several segments. The report illustrates each segment and sub-segment’s growth potential, market size, share, and future prospects.

The report thoroughly discusses important indicators of market growth, such as the analysis of the supply chain, value chain analysis and a compounded annual growth rate. The data presented will allow readers to understand in detail the quantitative and qualitative growth aspects of the Gene therapy market.

Alliance for Regenerative Medicine, Gilead Sciences, Inc., Novartis AG, Sibiono GeneTech Co. Ltd.and others are among the world’s leading players in the Gene therapy business. Such businesses harness the technological advances to extend their product reach and widen their choice of customers. To increase their versatility and willingness to adapt products to customer feedback, businesses are making use of technology to become more customer-centric.

Benefits of this report are-

    • It offers value for competitive level playing, giving the current giants as well as new entries equal status.

    • It will raise understanding of Gene therapy market’s overall outlook.

    • It is a strategic marketing approach to raise organisation, which makes it a totally helpful report, among other competitors.

    • -Helps to understand the current market scenario, as the report gives historical information on the space of the Gene therapy and makes future projections.

    • -The customized market segments will be examined depending on the region, country or even the different manufacturers in the Gene therapy .

Get ToC for the overview of the premium report https://www.quincemarketinsights.com/request-toc-60261?utm_source=campaign=Pooja/PF

Market Segmentation:

By Product:

• Yescarta

• Kymriah

• Luxturna

• Strimvelis

• Gendicine

By Application:

• Ophthalmology

• Oncology

• Adenosine

• Deaminase

• Deficient Severe Combined Immunodeficiency

By Region:

• North America

◦ North America, by Country

▪ US

▪ Canada

▪ Mexico

◦ North America, by Product

◦ North America, by Application

• Western Europe

◦ Western Europe, by Country

▪ Germany

▪ UK

▪ France

▪ Italy

▪ Spain

▪ The Netherlands

▪ Rest of Western Europe

◦ Western Europe, by Product

◦ Western Europe, by Application

• Asia Pacific

◦ Asia Pacific, by Country

▪ China

▪ India

▪ Japan

▪ South Korea

▪ Australia

▪ Indonesia

▪ Rest of Asia Pacific

◦ Asia Pacific, by Product

◦ Asia Pacific, by Application

• Eastern Europe

◦ Eastern Europe, by Country

▪ Russia

▪ Turkey

▪ Rest of Eastern Europe

◦ Eastern Europe, by Product

◦ Eastern Europe, by Application

• Middle East

◦ Middle East, by Country

▪ UAE

▪ Saudi Arabia

▪ Qatar

▪ Iran

▪ Rest of Middle East

◦ Middle East, by Product

◦ Middle East, by Application

• Rest of the World

◦ Rest of the World, by Country

▪ South America

▪ Africa

◦ Rest of the World, by Product

◦ Rest of the World, by Application

ABOUT US:

QMI has the most comprehensive collection of market research products and services available on the web. We deliver reports from virtually all major publications and refresh our list regularly to provide you with immediate online access to the world’s most extensive and up-to-date archive of professional insights into global markets, companies, goods, and patterns.

Contact Us

Quince Market Insights
Ajay D. (Knowledge Partner)
Office No- A109,
Pune, Maharashtra 411028
Phone: APAC +91 706 672 4848 / US +1 208 405 2835 / UK +44 1444 39 0986
Email: [email protected]
Web: www.quincemarketinsights.com

Categories
News

Gene Therapy Market Boosting the Healthcare Industry Worldwide

Transparency Market Research (TMR) has published a new report titled, “Gene Therapy Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global gene therapy market was valued at US$ 17.0 Mn in 2017 and is projected to expand at a CAGR of 40.0% from 2018 to 2026. New product approvals, promising therapeutic outcomes of gene therapy, and high prevalence of non-Hodgkin Lymphoma are anticipated to drive the global market in the next few years. Europe is projected to dominate the global gene therapy market, followed by U.S., by the end of 2026. Potential unmet needs in the fields of oncology, rare genetic disorders in the U.S. and Europe, new product approvals and commercialization, and high clinical R&D budgets are likely to drive the gene therapy market in these regions during the forecast period. The gene therapy market in Rest of World is projected to expand at a significant CAGR during the forecast period. The high growth rate is attributed to the anticipated approval and commercialization of gene therapy products in developed countries such as Japan, Australia & New Zealand, GCC countries, and China, and high prevalence of non-Hodgkin Lymphoma and head and neck cancers.

Request a PDF Sample – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1838

New product approvals & commercialization drives market

2016, 2017, and 2018 were key milestones in the history of the gene therapy market in the U.S. and Europe, as around four gene therapy products have been approved and commercialized. These products are currently in the infancy stage of commercialization, and have exhibited highly positive therapeutic outcomes. For instance, in May 2016, GlaxoSmithKline (GSK) gene therapy product, Strimvelis, received marketing approval for the treatment of patients with a very rare disease called ADA-SCID (Severe Combined Immunodeficiency, due to Adenosine Deaminase deficiency). Strimvelis is the first ex-vivo stem cell gene therapy to be approved in Europe for the treatment of ADA-SCID. Furthermore, in August 2017, the USFDA approved Novartis AG’s flagship gene therapy product, Kymriah, for the treatment of children and adults up to the age of 25 years affected with B-cell precursor acute lymphoblastic leukemia (ALL). Thus, recent approvals of gene therapy products in the U.S. and Europe for the treatment of various life threatening disorders is projected to fuel the gene therapy market during the forecast period.

Yescarta to be highest revenue generating gene therapy product

The report offers a detailed segmentation of the global gene therapy market based on different gene therapy products approved and commercialized. Based on product, the global gene therapy market has been segmented into Yescarta, Kymriah, Luxturna, Strimvelis, and Gendicine. Yescarta (Axicabtagene Ciloleucel) is a genetically modified autologous Chimeric Antigen Receptor T (CAR T) cell immunotherapy developed by Gilead Sciences, Inc. for the treatment of adult patients with relapsed or refractory large B-cell lymphoma including diffuse large B-cell lymphoma (DLBCL) and primary mediastinal large B-cell lymphoma (PMBCL). It is the first CAR T therapy approved by the US FDA for the treatment of DLBCL. The Yescarta segment is projected to dominate the global gene therapy market by the end of 2026. Anticipated commercialization of Yescarta in Europe and other developed countries and increasing number of treatment centers are key factors that are likely to lead to the dominant share held by Yescarta by the end of 2026.

Request for Analysis of COVID19 Impact on Gene Therapy Markethttps://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1838

Oncology segment to account for high market share

In terms of application, the global gene therapy market has been segmented into ophthalmology, oncology, and adenosine deaminase ?deficient severe combined immunodeficiency (ADA-SCID). The oncology segment is likely to account for a significant share of the market by the end of 2026. Oncology is a highly studied medical field in the clinical pipeline studies of gene therapy candidates. More than 60% of gene therapy clinical research studies are focused on oncology. The large share held by the oncology segment is attributed to the approval and commercialization of Yescarta and Kymriah, in the last one to two years, for the treatment of certain types of non-Hodgkin lymphoma in the U.S. and Europe. Furthermore, increase in demand for Gendicine in China for the treatment of head and neck cancers is projected to drive the segment during the forecast period.

Europe offers high incremental opportunity

The gene therapy market in Europe is projected to expand at a significant CAGR of 30.6% during the forecast period. Large number of patient population with refractory large B-cell lymphoma, including diffuse large B-cell lymphoma (DLBCL) and primary mediastinal large B-cell lymphoma (PMBCL), promising therapeutic outcomes, rising demand for gene therapy treatment, and increasing number of gene therapy treatment centers in Europe are key factors that are likely to fuel the gene therapy market in Europe. Moreover, different pricing models are being evaluated by payers and governments to enable access to high priced gene therapy products. This is likely to drive the demand for gene therapy products in Europe during the forecast period.

Request a PDF Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1838

Large number of clinical pipeline studies and significant investments in gene therapy to gain the first mover advantage

The global gene therapy market is highly consolidated, with very few global players accounting for a major share. Currently, only five companies; Gilead life Sciences Inc. Spark Therapeutic Inc., Novartis AG, Sibiono GeneTech Co. Ltd, and Orchard Therapeutics Limited offer gene therapy products in the market. Most biopharmaceutical companies have invested significantly in clinical R&D for the development of gene therapy products for different chronic and genetic disorders. Large number of gene therapy products are under different stages of clinical pipeline studies, and the number of gene therapy candidates is projected to rise consistently during the forecast period. For instance, according to the Journal of Gene Medicine, there were around 2,597 gene therapy candidates under clinical trials, as of 2017. Of the total clinical studies, around 65% of studies were focused on oncology, 11% of studies were focused on monogenetic field, 7% on infectious diseases and cardiovascular disease, each.

Purchase Gene Therapy Market Reporthttps://www.transparencymarketresearch.com/checkout.php?rep_id=1838&ltype=S

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,

90 Sate Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com

Read More Reports: https://www.prnewswire.com/news-releases/global-hemorrhoid-treatment-devices-market-to-grow-at-over-4-6-cagr-from-2018-to-2026-transparency-market-research-301001722.html

 

Categories
News

Gene Therapy Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2027

New Jersey, United States,- The Gene Therapy Market research report added by Verified Market Research is an in-depth analysis of the latest trends, market size, status, upcoming technologies, industry drivers, challenges, regulatory policies, with key company profiles and strategies of players. The research study provides market introduction, Gene Therapy market definition, regional market scope, sales and revenue by region, manufacturing cost analysis, Industrial Chain, market effect factors analysis, Gene Therapy market size forecast, 100+ market data, Tables, Pie Chart, Graphs and Figures, and many more for business intelligence.

The Gene Therapy Market report includes an in-depth analysis of the Gene Therapy market for the present as well as the forecast period. The report encompasses the competition landscape entailing share analysis of the key players in the Gene Therapy market based on their revenues and other significant factors. Further, it covers several developments made by the prominent players of the Gene Therapy market. The Gene Therapy Market report is a beneficial source of perceptive data for a business approach. It presents the market overview with growth analysis together with historical & futuristic costs. Further identifies the revenue, specifications, company profile, demand, and supply data.

Gene Therapy Market was valued at USD 3.69 Billion in 2019 and is projected to reach USD 24.78 Billion by 2027, growing at a CAGR of 26.9% from 2020 to 2027.

Leading Key players of Gene Therapy Market are:

  • Novartis AG
  • Biogen
  • Gilead Sciences
  • MolMed S.p.A.
  • Spark Therapeutics
  • Orchard Therapeutics plc.
  • SIBIONO
  • Bluebird bio
  • Shanghai Sunway Biotech
  • Human Stem Cells Institute

    Gene Therapy Market: Competitive Landscape

    This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

    Gene Therapy Market: Segment Analysis

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2019 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Gene Therapy Market, By Product

    • Viral Vectors
    o Adeno-associated virus vectors
    o Retroviral vectors
     Gammaretroviral vectors
     Lentiviral vectors
    o Other viral vectors (herpes simplex and adenoviral vectors)
    • Non-viral Vectors
    o Oligonucleotides
    o Other non-viral vectors (plasmids and RNAi)

    Gene Therapy Market, By Indication

    • Neurological Diseases
    • Cancer
    • Hepatological Diseases
    • Duchenne Muscular Dystrophy
    • Other Indications

    Gene Therapy Market, By Delivery Method

    • Ex vivo
    • In vivo

    Gene Therapy Market: Regional Analysis

    The research report includes a detailed study of regions of North America, Europe, Asia, and South America. The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, sales, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2026. These analyses will help the reader to understand the potential worth of investment in a particular region.

    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, and Italy)
    Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
    South America (Brazil, Argentina, Colombia, etc.)
    The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

    Why purchase this report

    • The report would provide a comprehensive analysis of the current and future market trends
    • Analysis of both global, regional and country lever markets
    • Key strategic initiatives are taken by major players operating in the Gene Therapy market along with ranking analysis for the key players
    • Analysis based on historical information along with the current trends to estimate the future of the market
    • Analysis of the impact of constantly changing global market scenarios on the market

     

    About us:

    Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals, and critical revenue decisions.

    Our 250 Analysts and SME’s offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.

    Contact us:

    Mr. Edwyne Fernandes

    US: +1 (650)-781-4080
    UK: +44 (203)-411-9686
    APAC: +91 (902)-863-5784
    US Toll-Free: +1 (800)-782—1768

    Email: [email protected]

  • Categories
    News

    Gene Therapy Market Size, Share, Global Future Trend, Segmentation, Business Growth, Top Key Players, Opportunities and Forecast to 2027

    New Jersey, United States,- The most recent Gene Therapy Market Research study includes some significant activities of the current market size for the worldwide Gene Therapy market. It presents a point by point analysis dependent on the exhaustive research of the market elements like market size, development situation, potential opportunities, and operation landscape and trend analysis. This report centers around the Gene Therapy business status, presents volume and worth, key market, product type, consumers, regions, and key players.

    The COVID-19 pandemic has disrupted lives and is challenging the business landscape globally. Pre and Post COVID-19 market outlook is covered in this report. This is the most recent report, covering the current economic situation after the COVID-19 outbreak.

     

    Key highlights from COVID-19 impact analysis:

    • A summary of the COVID-19 pandemic on the global economy.
    • Fluctuations in the demand and supply chain of the industry.
    • Pre and post-COVID-19 impact on the revenue matrix.

    Unveiling a brief about the Gene Therapy market competitive scope:

  • Bluebird Bio
  • Sangamo
  • Dimension Therapeutics
  • Avalanche Bio
  • Spark Therapeutics
  • Advantagene
  • Celladon
  • Vical Inc.

    The report includes pivotal details about the manufactured products, and in-depth company profile, remuneration, and other production patterns.

    The research study encompasses information pertaining to the market share that every company holds, in tandem with the price pattern graph and the gross margins.

    Gene Therapy Market, By Type

  • Ex vivo
  • In Vivo

    Gene Therapy Market, By Application

  • Cancer
  • Monogenic
  • Infectious disease
  • Cardiovascular disease
  • Other

    Other important inclusions in the Gene Therapy market report:

    • Key player players profiled in the Gene Therapy market
    • The report uncovers the production patterns and remuneration of each company across their territories.
    • In-depth company profile along with remuneration, pricing model, gross margins, and all other financial aspects are given as well.
    • Revenue share and sales volume estimates of each product type are validated in the report.
    • Substantial information concerning the production pattern, growth rate, and market share of each product type over the analysis period are underlined.
    • The research document also divides the Gene Therapy market based on the application scope.
    • The market share of each application together with their individual growth rate are listed.
    • Insights about the competitive dynamics, along with an analytical review of the industry supply are provided.
    • It further includes Porter’s five forces analysis as well as SWOT analysis to evaluate the feasibility of a new project.

     

    A brief overview of the regional landscape:

    • From a geographical perspective, the Gene Therapy market is partitioned into

      North America
      o U.S.
      o Canada
      o Mexico
      Europe
      o Germany
      o UK
      o France
      o Rest of Europe
      Asia Pacific
      o China
      o Japan
      o India
      o Rest of Asia Pacific
      Rest of the World

    • Contribution of each regional market, along with their projected growth rate over the evaluation period are contained in the report.
    • Sales amassed, revenue generated, and market share of each geography is also recorded.

    Reasons To Buy:

    • Analyzing the outlook of the market with the recent trends and SWOT analysis
    • Market dynamics scenario, along with growth opportunities of the market in the years to come
    • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects
    • Regional and country-level analysis integrating the demand and supply forces that are influencing the growth of the market.
    • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
    • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
    • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

     

    About Us:

    Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage, and more. These reports deliver an in-depth study of the market with industry analysis, the market value for regions and countries, and trends that are pertinent to the industry.

    Contact Us:

    Mr. Steven Fernandes

    Market Research Intellect

    New Jersey ( USA )

    Tel: +1-650-781-4080

  • Categories
    News

    Gene Therapy Market Statistics 2020 by Key Driving Factor, Dazzling Growth, Vital Players, Regions, Segments, Type, Treatment Type, Test & Outlook to 2027 | Top Companies – GlaxoSmithKline plc, Bluebird Bio, Inc., Adaptimmune Therapeutics plc, Celgene Corporation

    Impact Analysis of Covid-19

    The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

    Get Sample PDF Including COVID19 Impact Analysis Of Gene Therapy, https://www.coherentmarketinsights.com/insight/request-pdf/1774

    The Gene Therapy Market Research Report 2020 examines the competitive landscape, Market dynamics, and discusses major trends. The report offers the Recently update industry data on the actual and potential market situation, and future outlook.

    The research report begins with the Summary of Gene Therapy market comprising value chain analysis, sourcing strategy, and upstream and downstream buyers. The report encompasses the statistical analysis of Gene Therapy market Value, manufacturers, competition, and impact factors together with market forecast for 2020-2026. Gene Therapy Market analysis reports provide a valuable source of insightful data for business strategists and competitive analysis Gene Therapy. It also shows the value of production report, demand, industry share, growth, key segments, CAGR, Application, and key drivers.

    The next chapter exists deeper into company wise data including their market share, size, product information, and marketing channel information. The report also looks at the distribution channels and consumer Gene Therapy Market. The report then provides information about import, export, consumption data, and consumption value. The report then provides one of the most crucial aspects of the Gene Therapy Market – the forecast for the next five years based on the previous data as well as current data.

    In order to get a deeper view of Market Size, the competitive landscape is provided i.e. Revenue (Million USD) by Players (2015-2020), Revenue Market Share (%) by Players (2015-2020) and further a qualitative analysis is made towards market concentration rate, product/service differences, new entrants and the technological trends in future.

    It also going to elaborate the opportunities out there in micro niches for stakeholders to take a position, step by step investigation of the competitive landscape and even commodity professional services of famous players which include GlaxoSmithKline plc, Bluebird Bio, Inc., Adaptimmune Therapeutics plc, Celgene Corporation, Shanghai Sunway Biotech Co. Ltd., Merck KGaA, Transgene SA, and OncoGenex Pharmaceuticals, Inc.

    Key Features of Global Gene Therapy Market Research Report:

    • Detailed summary of key players operating in the Gene Therapy market with maximum industry share in terms of end-user demands, restraining factors, revenue, sales, products.

    • Investigate various attributes of Gene Therapy Market including growth and constraining factors, emerging technological advancement, opportunities, and leading segments of the Global Gene Therapy industry.
    • Rising trend of globalization, technological advancement, exceeding capacity in developed markets, and product escalation are studied in the Gene Therapy market report.
    • Diverse ranges of elements such as Gene Therapy production capacity, price, demand, supply chain/logistics, profit/loss, material parameters/specifications, and the growth factor have been reviewed in the Gene Therapy market report

    • Focuses on the global key manufacturers, to define, describe, and analyze the market competition landscape, SWOT analysis.

    This information assists in understanding the Gene Therapy market present and future trends, applications, and market challenges. The Gene Therapy Industrial consumers and other stakeholders to diversify their Gene Therapy market-centric strategies in proportion to the estimated and enduring trends in the industry.

    Competitive Analysis:

    The best long-term growth opportunities for this sector can be captured by ensuring ongoing process improvements and financial flexibility to invest in optimal strategies. Company profile section of players includes its basic information like legal name, website, headquarters, its market position, historical background, and top 5-6 closest competitors by Market revenue along with contact information. Each top vendors revenue figures, growth rate, and gross profit margin is provided in easy to understand tabular format for past 5 years and a separate section on recent development like mergers, acquisition or any new service launch, etc.

    About Us:

    Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

    To know more about us, please visit our website – www.coherentmarketinsights.com

    Contact us:

    Coherent Market Insights
    1001 4th Ave, #3200 Seattle, WA 98154, U.S.
    Email: [email protected]
    United States of America: +1-206-701-6702
    United Kingdom: +44-020-8133-4027
    Japan: +050-5539-1737
    India: +91-848-285-0837

    Categories
    News

    Gene Therapy Market Overview with Detailed Analysis, Competitive landscape, Forecast to 2027

    Gene Therapy Market

    The global Gene Therapy Market Report 2020 was prepared to provide the market landscape and unlimited guidelines for the current market size, market share, driving factors, Trends, progressive growth and the dominant players of the Gene Therapy Market . The report provides top manufacturers, distributors, dealers and dealers with general information about the market. It will help you to understand the product scope, the market overview, the driving force of the market, technological progress, market risk, opportunities and research results.

    Market Report world has monitored the Gene Therapy Market for the new Research Areas industrial market Gene Therapy Market was valued at USD 3.69 Billion in 2019 and is projected to reach USD 24.78 Billion by 2027, growing at a CAGR of 26.9% from 2020 to 2027.

    Our Reports on the Gene Therapy Market for the new Research Areas industrial market offer a holistic analysis, market size and forecast, Trends, growth drivers and challenges as well as a supplier analysis for about 25 suppliers.

    To request an exclusive sample report for Gene Therapy Market : https://www.verifiedmarketresearch.com/download-sample/?rid=40223&utm_source=PFS&utm_medium=001

    Global Gene Therapy Market research to 2020 provides a basic Overview of the industry including definitions, classifications, applications and structure of the industrial chain. The global Gene Therapy Market report is provided for international markets as well as for development trends, competitive landscape analyses and the development status of key regions. Development policies and plans are discussed and manufacturing processes and cost structures analyzed. This report also includes information on import / Export consumption, supply and demand, costs, Price, Sales and gross margins.

    List of the top key players of the Gene Therapy Market :

  • Novartis AG
  • Biogen
  • Gilead Sciences
  • MolMed S.p.A.
  • Spark Therapeutics
  • Orchard Therapeutics plc.
  • SIBIONO
  • Bluebird bio
  • Shanghai Sunway Biotech
  • Human Stem Cells Institute
  •  

    COVID-19 can influence the global economy in three ways: by directly influencing production and demand, by creating supply chain and market disruptions, and by having a financial impact on businesses and financial markets. The eruption of COVID-19 has implications for many aspects such as flight cancellations. Travel bans and quarantines; Restaurants closed; all Indoor Events restricted; over forty countries declared a state of emergency; massive supply chain slowdown; stock market volatility; falling business confidence, growing panic in the population and uncertainty about the future.

    This report examines the global Gene Therapy Market and analyses and examines the IoT in Education development status and forecast in the US, EU, Japan, China, India and Southeast Asia. This report focuses on the highest players in the global Gene Therapy Market .

     

    Ask For Discount @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=40223&utm_source=PFS&utm_medium=001

     

    The scope of the report covers all major system technologies currently being implemented in the global IoT in Education industry. Market values are supported the Top User (public and private) supports the production of IoT in Education systems. Gene Therapy Market manufacturers place orders as soon as they receive work orders from Gene Therapy Market operators. Therefore, market figures are derived from the perspective of the top users taking into account their orders (Gene Therapy Market operator) for the Gene Therapy Market .

    With this report, you can identify the opportunities in the Gene Therapy Market by Region:

    – North America (USA, Canada and Mexico)

    – Europe (Germany, Great Britain, France, Italy, Russia and Turkey etc.)

    – Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia (Indonesia, Thailand, Philippines, Malaysia and Vietnam))

    -South America (Brazil, etc.)

    – The Middle East and Africa (North Africa and GCC countries)

     

    The Gene Therapy Market was created on the basis of an in-depth market analysis with contributions from industry experts. The report covers the growth prospects in the coming years and the discussion of the main providers.

    Gene Therapy Market Dynamics:

    Market drivers

    Increasing deforestation due to increasing demand for increasing raw materials

    For a full, detailed list, see our report

     

    Market Challenge

    Risks associated with the use of IoT in Education

    For a full, detailed list, see our report

     

    Market Trend

    Increasing consumer preference for IoT in Education
    For a full, detailed list, see our report

    The global market research report of IoT in Education industry 2020 is distributed over several pages and contains exclusive Statistics, data, information, Gene Therapy Market trends and details of the competitive landscape in this niche sector.

    To understand how the effects of COVID-19 are addressed in this report. A sample copy of the report is available at – https://www.verifiedmarketresearch.com/product/gene-therapy-market/?utm_source=PFS&utm_medium=001

    Research objectives of the Gene Therapy Market report:

    -To analyze IoT in Education consumption (value and volume), product type and Application, History data from 2015 to 2020 and forecast.

    -To understand the structure of the Gene Therapy Market , identify the different sub-segments.

    – Focuses on the most important IoT in Education manufacturers to define, describe and analyze sales volume, value, market share, market competition landscape, STREBER analysis and development plans in the coming years.

    – To analyze the Gene Therapy Market taking into account individual growth trends, future prospects and their contribution to the overall market

    – Detailed information on the key factors influencing the Expansion of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

    – To analyze competitive developments such as extensions, agreements, product launches and acquisitions within the company

    – To strategically profile the main players and to comprehensively analyse their growth strategies.

    The report also focuses on the world’s leading industry players in the global Gene Therapy Market , providing information such as company profiles, product images and specifications, capacity, production, price, cost, revenue and contacting information. In addition, upstream raw materials and equipment as well as downstream demand analyses are managed. The global Gene Therapy Market development trends and market channels are analyzed. Finally, the feasibility of the latest investment projects is evaluated and general research results are offered. With tables and figures to help analyze the global Gene Therapy Market , this study provides important statistics on the state of the industry and can be a valuable guide and guidance for companies and individuals who are curious about the market.

    Reason for buying Gene Therapy Market report:

    – This report provides a pinpoint analysis of the change in competitive dynamics

    – Gene Therapy Market provides a forward-looking perspective on various factors that drive or inhibit market growth.

    – It includes a six-year forecast, which is assessed on the basis of expected market growth

    – Better understanding of the effects of specific conditions on the prevailing population of the Gene Therapy Market .

    – To understand the most important product segments and their future

    – Transfer of more accurate information for clinical trials to determine research size and realistic recruitment for different countries

    – Gene Therapy Market helps with sound business decisions by having complete insights into the market and analyzing market segments in depth

    -To provide distinctive graphics and exemplary STREBER analysis of the most important market segments

    About us:

    Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals, and critical revenue decisions.

    Our 250 Analysts and SME’s offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.

    Contact us:

    Mr. Edwyne Fernandes

    US: +1 (650)-781-4080
    UK: +44 (203)-411-9686
    APAC: +91 (902)-863-5784
    US Toll-Free: +1 (800)-782—1768

    Email: [email protected]